Mountain River Pharmaceutical: It is expected that the net profit will increase by 38.16% - 62.45% compared to the previous year by 2025.

Shanhe Pharmaceutical announced that it is expected to have a net profit of 165 million to 194 million yuan in 2025, an increase of 38.16%-62.45% compared to the previous year. With the market's demand for high-quality products, the company is benchmarking imported products and continuing to increase investment in research and development to ensure comprehensive quality consistency. Thanks to the company's research and development capabilities and good brand influence, customers have a high dependence on the company's products. During the reporting period, the company's main product business orders have been relatively sufficient, showing a clear growth trend.